Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation (NASDAQ: VREX) is a designer and manufacturer of X-ray imaging components and systems used in medical, industrial, and security applications. The VREX news page on Stock Titan aggregates company announcements, earnings releases, conference presentations, and product-related updates so readers can follow how the business is evolving over time.
Recent news for Varex has focused on quarterly and annual financial results, including detailed segment reporting for its Medical and Industrial businesses, as well as reconciliations between GAAP and non-GAAP financial measures. Earnings releases typically discuss revenue trends in medical X-ray components, demand in industrial imaging, and developments affecting specific markets such as China. Management commentary often highlights factors such as segment performance, margins, cash flow from operations, and capital structure items like convertible notes and senior secured notes.
In addition to financial results, Varex issues news about orders and deployments of its high-energy non-intrusive cargo and vehicle inspection systems. These announcements describe international customers placing systems at strategic sea and land ports and reference the company’s reputation in high-energy Linear Accelerator based imaging. The news flow also includes updates on investor conference appearances, where management presents at events hosted by firms such as CJS Securities, Sidoti, and Jefferies.
Visitors to the VREX news page can use this stream of press releases and updates to monitor trends in medical imaging components, industrial and security imaging systems, cargo inspection orders, and corporate developments. Bookmarking the page allows investors and observers to review new announcements alongside prior releases for context on Varex Imaging Corporation’s ongoing disclosures.
Varex Imaging Corporation (Nasdaq: VREX) has launched the LUMEN 4336W digital radiography detector, enhancing its product line with features prioritizing durability and convenience. This new detector features a robust design with an IP68 rating, ensuring water resistance for real-world applications. It emphasizes reliability through a simplified internal structure and incorporates wireless charging capabilities. Varex continues to guarantee high image quality, leveraging its expertise in X-ray imaging technology.
Varex Imaging Corporation (Nasdaq: VREX) announced a partial redemption of $30 million from its $300 million 7.875% senior secured notes due 2027, effective July 15, 2021. The redemption price is set at 103% of the principal amount plus accrued interest since April 15, 2021. CFO Sam Maheshwari highlighted that improved financial performance is enabling debt reduction and decreased interest expenses, indicating a positive cash generation trend for the company.
Varex Imaging Corporation (Nasdaq: VREX) is set to present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 9:30 am ET. The company's CFO, Sam Maheshwari, will discuss Varex’s business and future prospects during the presentation. This event will be available via webcast, with replays accessible for 90 days on the company's website, vareximaging.com. Varex, headquartered in Salt Lake City, Utah, specializes in X-ray imaging components used in medical and industrial applications, boasting over 70 years of innovation.
Varex Imaging Corporation (Nasdaq: VREX) reported strong financial performance for 2QFY21, with revenues of $204 million, a 15% sequential increase, and a 3% year-over-year rise. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 35%. Net earnings were $0.08 per diluted share for GAAP and $0.35 for non-GAAP. Positive drivers included robust global sales of CT tubes and industrial digital detectors. Cash flow from operations reached $13 million, and cash and equivalents stood at $111 million by quarter end.
Varex Imaging Corporation (Nasdaq: VREX) will report its unaudited financial results for Q2 of fiscal year 2021 on May 4, 2021, after market close. A conference call is scheduled for the same day at 3:00 p.m. Mountain Time, accessible through the company's website or via phone. Varex specializes in X-ray imaging components and has over 70 years of innovation, providing solutions for medical, industrial, and security imaging applications. The company employs around 2,000 people globally, reflecting its strong presence in the imaging sector.
Varex Imaging Corporation (Nasdaq: VREX) will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 1:10 pm ET. The company’s CFO, Sam Maheshwari, will discuss Varex’s business and future prospects. The presentation will be webcast and accessible on the company’s website, with replays available for 90 days. Varex specializes in designing and manufacturing X-ray imaging components, playing a crucial role in medical and industrial applications, with over 2,000 employees worldwide.
Varex Imaging Corporation (Nasdaq: VREX) reported its 1QFY21 financial results, showing revenues of $177 million, a 4% increase sequentially from 4QFY20. The company achieved a GAAP gross margin of 32% and a non-GAAP gross margin of 34%, reflecting a 580 basis points improvement due to cost reductions and a favorable product mix. GAAP net earnings were $(0.16) per diluted share, while non-GAAP earnings were $0.08. The outlook for 2QFY21 estimates revenues between $180 million and $200 million and non-GAAP earnings per diluted share between $0.05 and $0.25.
Varex Imaging Corporation (Nasdaq: VREX) will release its unaudited financial results for Q1 FY2021 on February 4, 2021, after market close. A conference call is scheduled for 3:00 PM MT the same day, available via webcast on the company’s investor site and through designated phone numbers. The replay will be accessible until February 18, 2021. Varex Imaging specializes in X-ray imaging components, with over 70 years of innovation in medical, industrial, and security applications, employing about 2,000 staff globally.
Varex Imaging Corporation (Nasdaq: VREX) will present at two virtual investor conferences in January 2021. The first is at the CJS Securities 21st Annual New Ideas for the New Year Conference on January 13, 2021, at 1:35 pm ET. The second presentation is at the Sidoti Winter 2021 Investor Conference on January 14, 2021, at 11:30 am ET. CFO Sam Maheshwari will discuss Varex's business and future prospects. Webcast links are available for both events, and replays will be accessible for 90 days on the company's website.
Varex Imaging Corporation (Nasdaq: VREX) announced its 2021 Annual Meeting of Stockholders will be held virtually on February 11, 2021, at 2:00 PM Mountain Time due to COVID-19 restrictions. Stockholders of record as of December 18, 2020, are eligible to vote on meeting matters. Varex will provide necessary information on attending the virtual meeting and encourages stockholders to vote and submit proxies in advance. Varex is a leader in X-ray imaging components, supplying products for medical, industrial, and security applications, employing approximately 2,000 people globally.